Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Ad…

@radioncoluis @sara_m88 Currently we have an open trial in India exploring the use of Ultrafractionationated post OP RT to the breast with nodal positivity.This would be hopefully augment the evidence for N+ along with the nodal substudy in Fast Forward. @

Full text of the #hyportadjuvant trial #bcsm #radonc #hypofractionation. One of the few multicentric trials from India. https://t.co/P1a8mEY1bu